Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Hayat

Showing results (181-190 of 299) with videos related to

Pageof 30
Sort By:
Revue Europeenne D'Etudes Cliniques Et Biologiques. European Journal of Clinical and Biological Research|March 1, 1971
Preliminary result of a new protocol for the active immunotherapy of acute lymphoblastic leukaemia: inhibition of the immunotherapeutic effect by Vincristine or AdamantadineG Mathé, J L Amiel, L Schwarzenberg, et al.
Bulletin Du Cancer|April 1, 1974
[Controlled therapeutic trial of combined radiotherapy-chemotherapy in Hodgkin's disease]M Tubiana, G Mathé, M Hayat, et al.
Bulletin Du Cancer|July 1, 1974
[Cytological classification of 100 cases of acute lymphoid leukemia: factor of prognosis after immunotherapy]G Mathé, P Pouillart, J L Amiel, et al.
La Presse Medicale|September 26, 1970
[Allogenic bone marrow graft after conditioning with only antilymphocytic serum in states of bone marrow aplasias]J L Amiel, G Mathe, L Schwarzenberg, et al.
Transplantation Proceedings|March 1, 1971
Bone marrow graft in man after conditioning by antilymphocytic serumG Mathé, J L Amiel, L Schwarzenberg, et al.
Leukemia|November 1, 1995
Intensive chemotherapy for poor prognosis myelodysplasia (MDS) and secondary acute myeloid leukemia (sAML) following MDS of more than 6 months duration. A pilot study by the Leukemia Cooperative Group of the European Organisation for Research and Treatment in Cancer (EORTC-LCG)T de Witte, S Suciu, M Peetermans, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 1, 1995
Can clinical data help to screen patients with lymphoma for MR imaging of bone marrow?A A Tardivon, J N Munck, L G Shapeero, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1978
Preliminary results of a phase II trial of aclacinomycin in acute leukaemia and lymphosarcoma. An oncostatic anthracyclin that is rarely cardiotoxic and induces no alopeciaG Mathé, M Bayssas, J Gouveia, et al.
Bone Marrow Transplantation|January 1, 1991
Lack of correlation between serum levels and receptor expression of TNF alpha and graft versus host disease following allogeneic bone marrow transplantationE Robinet, J L Pico, A Ibrahim, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1993
High-dose chemotherapy with etoposide, cyclophosphamide and escalating dose of carboplatin followed by autologous bone marrow transplantation in cancer patients. A pilot studyA Ibrahim, E Zambon, J H Bourhis, et al.
Pageof 30

Showing results (181-190 of 299) with videos related to

Sort By:
Pageof 30
Revue Europeenne D'Etudes Cliniques Et Biologiques. European Journal of Clinical and Biological Research|March 1, 1971
Preliminary result of a new protocol for the active immunotherapy of acute lymphoblastic leukaemia: inhibition of the immunotherapeutic effect by Vincristine or AdamantadineG Mathé, J L Amiel, L Schwarzenberg, et al.
Bulletin Du Cancer|April 1, 1974
[Controlled therapeutic trial of combined radiotherapy-chemotherapy in Hodgkin's disease]M Tubiana, G Mathé, M Hayat, et al.
Bulletin Du Cancer|July 1, 1974
[Cytological classification of 100 cases of acute lymphoid leukemia: factor of prognosis after immunotherapy]G Mathé, P Pouillart, J L Amiel, et al.
La Presse Medicale|September 26, 1970
[Allogenic bone marrow graft after conditioning with only antilymphocytic serum in states of bone marrow aplasias]J L Amiel, G Mathe, L Schwarzenberg, et al.
Transplantation Proceedings|March 1, 1971
Bone marrow graft in man after conditioning by antilymphocytic serumG Mathé, J L Amiel, L Schwarzenberg, et al.
Leukemia|November 1, 1995
Intensive chemotherapy for poor prognosis myelodysplasia (MDS) and secondary acute myeloid leukemia (sAML) following MDS of more than 6 months duration. A pilot study by the Leukemia Cooperative Group of the European Organisation for Research and Treatment in Cancer (EORTC-LCG)T de Witte, S Suciu, M Peetermans, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 1, 1995
Can clinical data help to screen patients with lymphoma for MR imaging of bone marrow?A A Tardivon, J N Munck, L G Shapeero, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1978
Preliminary results of a phase II trial of aclacinomycin in acute leukaemia and lymphosarcoma. An oncostatic anthracyclin that is rarely cardiotoxic and induces no alopeciaG Mathé, M Bayssas, J Gouveia, et al.
Bone Marrow Transplantation|January 1, 1991
Lack of correlation between serum levels and receptor expression of TNF alpha and graft versus host disease following allogeneic bone marrow transplantationE Robinet, J L Pico, A Ibrahim, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1993
High-dose chemotherapy with etoposide, cyclophosphamide and escalating dose of carboplatin followed by autologous bone marrow transplantation in cancer patients. A pilot studyA Ibrahim, E Zambon, J H Bourhis, et al.
Pageof 30